577 abstracts found.



Results filter

Genome-epigenome interplay in medulloblastoma

Year:

Session type:

Theme:

Paul Northcott1
1St. Jude Children's Research Hospital

Translocations and catastrophe – chromothriptic disruption of transcription factors in ependymoma

Year:

Session type:

Theme:

Richard Gilbertson1
1Cancer Research UK Cambridge Institute

Comprehensive analysis of cell-free tumour DNA in plasma and urine tracks disease burden and reveals clonal evolution in muscle invasive bladder cancer

Year:

Session type:

Theme:

Christopher Smith1,Kristan van der Vos2,Keval Patel1,Charles Massie1,Francesco Marass1,James Morris1,Dana Tsui1,Florent Mouliere1,Vincent Gnanapragasam1,Tim Forshew3,Bas van Rhijn2,Nitzan Rosenfeld1,Michiel van der Heijden2
1University of Cambridge,2Netherlands Cancer Institute,3University College London

Molecular Profiling of Circulating Tumour Cells (CTCs) in Non-small cell lung cancer within the TRACERx study of Intratumoural Heterogeneity and Evolution

Year:

Session type:

Theme:

Sakshi Gulati1,Francesca Chemi2,Dominic G Rothwell2,Deborah Burt2,Barbara Mesquita2,Christopher Wirth2,Gareth Wilson3,Jackie Pierce2,Ged Brady2,Charles Swanton4,Caroline Dive5
1Postdoctoral Scientist,2Cancer Research UK Manchester Institute,3The Francis Crick Institute,London, UK,4The Francis Crick Institute,London, UK and and on behalf of TRACERx consortium and Cancer Research UK Manchester/UCL Lung Cancer Centre of Excellence,5Cancer Research UK Manchester Institute and on behalf of TRACERx consortium and Cancer Research UK Manchester/UCL Lung Cancer Centre of Excellence

F-18 labelled 3’-deoxy-3’-fluorothymidine (FLT) positron emission tomography (PET) imaging in patients with advanced pancreatic ductal adenocarcinoma: proof-of-concept reproducibility sub-analysis.

Year:

Session type:

Theme:

Angela Lamarca1,Prakash Manoharan2,Marie-Claude Asselin3,Peter J Julyan4,Mahbubunnabi Tamal3,Ioannis Trigonis3,Mairéad G McNamara5,Richard A Hubner1,Zarni Win6,Juan W Valle5,Azeem Saleem7
1Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom,2Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom,3University of Manchester Wolfson Molecular Imaging Centre (WMIC), Institute of Population Health, Manchester, United Kingdom,4Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, United Kingdom,5Department of Medical Oncology, The Christie NHS Foundation Trust; Institute of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom,6Department of Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom,7Department of Applications, Imanova Centre for Imaging Sciences, London, United Kingdom

Rhabdovirus based oncolytic virus vaccines

Year:

Session type:

Theme:

John Bell1
1Ottawa Hospital Research Institute

Systemic delivery of Enadenotucirev, a Group B oncolytic Adenovirus for the treatment of cancer

Year:

Session type:

Theme:

Kerry Fisher1
1University of Oxford

How should we combine oncolytic virotherapy with other agents?

Year:

Session type:

Theme:

Kevin Harrington1
1The Institute of Cancer Research

Inhibiting HOX-PBX binding in paediatric glioblastoma as a novel therapeutic treatment

Year:

Session type:

Theme:

William Rogers1,Richard Morgan2,Hardev Pandha1
1University of Surrey,2University of Bradford

Deep sequencing of circulating tumour DNA for personalised cancer detection and monitoring

Year:

Session type:

Theme:

Maximilian Diehn1
1Stanford University

Page 3 of 58« First...3...25...Last »